GB00BMVP7Y09
GB00BMVP7Y09
Royalty Pharma plc
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 32.9B EUR | 24.99B EUR | 21.28B EUR | 16.56B EUR |
Enterprise Value | 36.11B EUR | 33.14B EUR | 29.65B EUR | 24.9B EUR |
Valuation Multiples | ||||
Trailing P/E | 30.28x | 30.67x | 25.66x | 30.98x |
Forward P/E | 9.82x | -- | -- | -- |
Price to Sales | 12.97x | 9.86x | 8.72x | 9.15x |
Price to Book | 3.71x | 3.66x | 3.09x | 2.56x |
EV/Revenue | 14.24x | 13.07x | 12.15x | 13.76x |
EV/EBITDA | 23.18x | 20.16x | 17.22x | 23.42x |
Price to FCF (P/FCF) | -- | 8.4x | 8.15x | 8.75x |
EV/FCF | -- | 11.13x | 11.35x | 13.15x |
FCF Yield | -3.63% | 11.91% | 12.27% | 11.43% |